ProCE Banner Series

Shining a Light on HER2-Low and HER2-Ultralow Metastatic Breast Cancer: A Pathologist’s Guide to Bridging the Diagnostic Gaps

In this live, interactive webinar, leading pathology and oncology experts will help learners improve their knowledge, confidence, and competence with accurately performing pathological assessment, diagnosis, and evidence-based treatment strategies for patients with HER2-low or HER2-ultralow metastatic breast cancer.

To register for the in-person meeting, please register here: https://2025am.uscap.org/

  AMA
Who Should Attend

This educational activity is intended for pathologists, oncologists, and other laboratory and healthcare professionals involved in the precision care of patients with HER2-low/ultralow metastatic breast cancer.

All Events

Shining a Light on HER2-Low and HER2-Ultralow Metastatic Breast Cancer: A Pathologist’s Guide to Bridging the Diagnostic Gaps

Upcoming Events

March

25

2025

6:30 AM - 7:30 AM Eastern Time (ET)

Virtual

Boston Convention and Exhibition Center, 415 Summer Street, Boston, Massachusetts 02210

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners' knowledge, confidence, and competence in accurately performing pathological assessment, diagnosing, and providing evidence-based treatment strategies for patients with HER2-low/ultralow metastatic breast cancer.

Target Audience
This educational activity is intended for pathologists, oncologists, and other laboratory and healthcare professionals involved in the precision care of patients with HER2-low/ultralow metastatic breast cancer.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Score HER2 levels via immunohistochemistry (IHC) in routine and complex breast cancer cases in accordance with guidelines and expert opinion

  • Implement pathological procedures to identify patients with metastatic breast cancer who may benefit from HER2-targeted therapy through optimal assessment of HER2 status, and streamline communication of results

  • Select novel HER2-targeted therapies for treatment of patients with HER2-low/ultralow metastatic breast cancer based on clinical data, guideline recommendations, and patient-/disease-related factors

     

     

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Pathology Continuing Certification 

A blue and white microscopeDescription automatically generated with low confidence

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Lifelong Learning point in the American Board of Pathology’s Continuing Certification Program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABPath Continuing Certification (formerly Maintenance of Certification or MOC) credit. 

For ABPath Lifelong Learning points, your information will be shared with the ABPath through CCO’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your Lifelong Learning points to appear on your ABPath records. 

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS). 

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.